Cohesys Reports First-in-Human for BoneTape Craniofacial Fracture Repair

Cohesys, a Toronto-based developer of resorbable fixation technologies, announced the first patients have undergone treatment with BoneTape, an investigational device for fixation of non-load bearing craniofacial fractures.

The company said the procedures were done as planned as mark the first clinical use of its drill- and screw-free fixation system. Device- and procedure-related risks—which include infection, non-union, and re-operation—will be monitored throughout the study’s follow-up period.

BoneTape is applied with a handheld applicator that affixes the resorbable fixation device to bone surfaces without drilling or screws. The study will determine if the design performs as intended and potentially spare patients from device-related complications and the need for hardware-removal procedures.

Dr. Jeffrey A. Fialkov, MD, MSc, FRCSC, Head of the Division of Plastic and Reconstructive Surgery at Sunnybrook Health Sciences Centre, Associate Professor in the Department of Surgery at the University of Toronto, and Principal Investigator for the study said this marks an exciting step forward, and affirmed his privilege to be part of an effort exploring new techniques in facial fracture treatment.

“BoneTape’s hardware-free approach is intended to simplify surgery and may improve the recovery experience for patients,” Dr. Fialkov told the press.

“Reaching this milestone is significant for Cohesys as we evaluate BoneTape’s potential to offer a simpler, patient-friendly approach to fracture repair,” said Dr. Michael Floros, CEO of Cohesys. “The data from this study will inform our regulatory strategy and commercialization pathway.”

The company was launched in June 2024 through Alto Capital, a wholly-owned subsidiary.